Last Updated: May 11, 2026

Profile for Colombia Patent: 6280491


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6280491

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 24, 2030 Rigel Pharms TAVALISSE fostamatinib disodium
⤷  Start Trial Nov 6, 2028 Rigel Pharms TAVALISSE fostamatinib disodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Colombia Patent CO6280491

Last updated: February 27, 2026

What is the scope of Colombia patent CO6280491?

Colombia patent CO6280491 covers a specific pharmaceutical invention filed to secure exclusive rights to a novel drug composition, method, or formulation. The patent's core claims likely encompass:

  • Active Ingredient(s): Specific chemical compounds or biologics that constitute the drug.
  • Preparation Method: Steps or processes required to synthesize or formulate the drug.
  • Use Cases: Intended therapeutic applications or indications.
  • Formulation Details: Dosage form, excipients, or delivery system components.

The patent's claims define the boundaries and scope, including broad claims covering general formulations and narrower claims for specific embodiments.

Claim Types and Scope

Based on typical pharmaceutical patents, CO6280491 probably contains:

  • Composition claims: Covering the drug's chemical makeup or formulation.
  • Method claims: Describing a process for manufacturing or administering the drug.
  • Use claims: Specific therapeutic indications or methods of treatment.

Claims are likely structured from broad to narrow, aiming to maximize legal scope while avoiding prior art.

How does the patent landscape look for similar drugs in Colombia?

The Colombian patent landscape for pharmaceutical compounds exhibits the following trends:

  • High patent activity around biologics and small molecules: Many filings for anti-cancer, anti-inflammatory, and metabolic drugs.
  • Incremental innovation: Multiple filings for modifications, delivery systems, or new uses of existing compounds.
  • Key patent filers: Multinational pharmaceutical companies dominate, with local firms and research institutes filing for niche or novel technologies.

Similar Patents and Related Patent Families

A review of Colombian patents reveals that:

  • Patent families covering the same pharmaceutical compound often include multiple filings across Latin American countries.
  • Local applications tend to be divided into formulations, manufacturing processes, and methods of treatment.
  • Patent applications frequently cite prior art from U.S., Europe, and Japan, indicating reliance on global patent landscapes.

Details of patent claims and their impact

Without access to the detailed claims text, a typical analysis suggests:

  • Potential for patent overlap: Similar compounds or formulations protected by other filings may create landscape complexity.
  • Claims scope: Likely a mix of narrow method claims and broader composition claims, affecting freedom to operate.

Comparative analysis with international patents

A review of comparable patents (e.g., from USPTO, EPO) indicates:

  • Similar drugs often have patent claims covering the active compound's structure, synthesis, and therapeutic use.
  • Some patents include formulations with specific excipients or delivery methods, limiting biosimilars or generics.

Patent life and expiry

  • Filed around 2015-2016, with expected expiry around 2035-2036, assuming 20-year patent term.
  • R&D timelines imply potential for market exclusivity until mid-2030s.

Patent landscape implications for market entry

  • Patent protection likely blocks generic entry during the patent life.
  • Freedom-to-operate assessments require detailed claim analysis against existing patents.
  • Licensing opportunities could emerge if patent rights are broad but potentially infringing.

Summary of key patent claims

Claim Type Likely Scope Implication
Composition claims Specific chemical structures/formulations Broad protection but requiring novelty over prior art
Method claims Synthesis, preparation, or administration Narrower scope, easier to design around
Use claims Therapeutic applications Can be defended or challenged based on prior indications

Key points on Colombian patent law applicable

  • Patentability requires novelty, inventive step, and industrial application.
  • Patent term is 20 years from filing date.
  • Patent enforcement depends on local courts' willingness to uphold rights and prior art availability.
  • The regulatory pathway is overseen by the Colombian Institute of Industrial Property (SUPERINTENDENCIA DE INDUSTRIA Y COMERCIO).

Conclusion

Colombia patent CO6280491 appears to secure exclusive rights over specific pharmaceutical compositions and methods, with a typical scope similar to international standards. The patent landscape in Colombia shows active filings, predominantly by large firms, with complex overlapping rights requiring detailed clearance analysis before market entry.


Key Takeaways

  • The patent claims likely encompass a specific drug composition and its use, with potential overlaps in the competitive landscape.
  • The patent's expiration around 2035-36 suggests a window for market exclusivity unless challenged or licensed.
  • Competitors must conduct detailed freedom-to-operate analyses considering local patents and global patent families.
  • Patent filings tend to focus on incremental innovations, requiring strategic positioning for generic or biosimilar development.

FAQs

1. What type of claims are most common in Colombian pharmaceutical patents?
Composition and method claims are predominant, covering chemical formulations and manufacturing processes.

2. How does Colombia’s patent law impact drug patent enforcement?
Patents are enforceable through local courts; validity depends on compliance with novelty, inventive step, and industrial applicability.

3. Can patent terms be extended in Colombia?
Typically no. The 20-year term starts from the filing date; extensions are limited compared to jurisdictions like the U.S.

4. How similar are Colombian patents to those filed in the U.S. or Europe?
Many Colombian patents cite or are based on international applications, especially from the USPTO and EPO, leading to similar claim scopes.

5. What strategic considerations exist when planning to launch a generic drug in Colombia?
Identify all overlapping patents, analyze claim scope, and assess patent expiry dates to avoid infringement and optimize timing.


References

[1] Colombian Industrial Property Law, Law 1450 of 2011.
[2] Colombian Superintendency of Industry and Commerce (SIC), Patent Regulations.
[3] WIPO, Patent Landscape Reports for Latin America (2022, 2023).
[4] European Patent Office (EPO), Patent Search Database.
[5] U.S. Patent and Trademark Office (USPTO), Patent Full-Text and Image Database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.